Skip to main content
. 2014 Nov 14;1:10.3402/ecrj.v1.25037. doi: 10.3402/ecrj.v1.25037

Fig 2.

Fig 2

The oral corticosteroid dose reduction in 13 studies with methotrexate as corticosteroid-sparing agent (Table 2). Corticosteroid doses pre and post methotrexate treatment are shown. The size of dot reflects the number of patients in each study. The regression coefficient is 0.35 and equivalent to a mean reduction of 35%.